Stefanini, B.; Ielasi, L.; Casadei-Gardini, A.; Piscopo, M.; Tortora, R.; Lani, L.; Pressiani, T.; Sansone, V.; Sacco, R.; Magini, G.;
et al. Repeated Previous Transarterial Treatments Negatively Affect Survival in Patients with Hepatocellular Carcinoma Receiving Sorafenib. Gastroenterol. Insights 2024, 15, 519-529.
https://doi.org/10.3390/gastroent15030038
AMA Style
Stefanini B, Ielasi L, Casadei-Gardini A, Piscopo M, Tortora R, Lani L, Pressiani T, Sansone V, Sacco R, Magini G,
et al. Repeated Previous Transarterial Treatments Negatively Affect Survival in Patients with Hepatocellular Carcinoma Receiving Sorafenib. Gastroenterology Insights. 2024; 15(3):519-529.
https://doi.org/10.3390/gastroent15030038
Chicago/Turabian Style
Stefanini, Bernardo, Luca Ielasi, Andrea Casadei-Gardini, Michele Piscopo, Raffaella Tortora, Lorenzo Lani, Tiziana Pressiani, Vito Sansone, Rodolfo Sacco, Giulia Magini,
and et al. 2024. "Repeated Previous Transarterial Treatments Negatively Affect Survival in Patients with Hepatocellular Carcinoma Receiving Sorafenib" Gastroenterology Insights 15, no. 3: 519-529.
https://doi.org/10.3390/gastroent15030038
APA Style
Stefanini, B., Ielasi, L., Casadei-Gardini, A., Piscopo, M., Tortora, R., Lani, L., Pressiani, T., Sansone, V., Sacco, R., Magini, G., Renzulli, M., Foschi, F. G., Piscaglia, F., Tovoli, F., & Granito, A.
(2024). Repeated Previous Transarterial Treatments Negatively Affect Survival in Patients with Hepatocellular Carcinoma Receiving Sorafenib. Gastroenterology Insights, 15(3), 519-529.
https://doi.org/10.3390/gastroent15030038
